Gregory Piazza on Identifying Thromboprophylaxis and Aspirin Use in Pregnancy
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on LinkedIn:
”Very proud of this collaboration with my dear friend and colleague, Dr. Elvira Grandone.
Antithrombotic care in pregnancy is a challenging clinical concern and Italian MoMs sheds some light on the situation!”
Read the full article here.
Article: Identifying Thromboprophylaxis and Aspirin use in pregnancy: predictors and Maternal outcomes – the Italian MoMs Study
Authors: Elvira Grandone, Mario Mastroianno, Felice Sorrentino, Gabriella Cicerone, Donatella Colaizzo, Leonardo Latino, Lorenzo Lomuzio, Stefano Bettocchi, Lucia Mirabella, Angelo Ostuni, Antonio De Laurenzo, Francesca Gorgoglione, Tiziana Palladino, Pasquale Vaira, Antonella Vimercati, Ettore Cicinelli, Behnood Bikdeli, Eleni Kaldouidi, Gregory Piazza, Maurizio Margaglione
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids